Solve M.E. and The Biotechnology Innovation Organization (BIO) will co-host a three-hour virtual event “Long Covid: What Will It Take to Accelerate Therapeutic Progress?” on Tuesday, February 21 from 10:00 AM – 1:00 PM PT (1:00 – 4:00 PM ET).
Our goal is to convene stakeholders to advance research and development to diagnose and treat Long Covid, ME/CFS, and other post-infection diseases. By increasing awareness among drug developers to the unmet needs of our communities, we hope to inspire these industry players to study these diseases and create therapeutic breakthroughs.
The session will establish a knowledge base of emerging research in Long Covid and existing body of data in other post-infection diseases (such as myalgic encephalomyelitis/chronic fatigue syndrome, dysautonomia, mast cell activation, and others). The session also will feature solution-oriented perspectives from government, academic, and industry researchers, patient groups, funding sources, and policymakers.
Hosts:
Opening Remarks:
Speakers:
Solve M.E. is a non-profit organization that serves as a catalyst for critical research into diagnostics, treatments, and cures for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), Long Covid and other post-infection diseases.
BIO is the world’s largest advocacy association representing member companies, state biotechnology groups, academic and research institutions, and related organizations across the United States and in 30+ countries.
350 N Glendale Ave.
Suite B #368
Glendale, CA 91206
SolveCFS@SolveCFS.org
704-364-0016
EIN: 56-1683450
Join the Solve Together Real-World Data Platform
